These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31396017)

  • 1. The Influence of Inflammation on Fibrinogen Turnover and Redistribution of the Hemostatic Balance to a Prothrombotic State in High On-Treatment Platelet Reactivity-Dual Poor Responder (HTPR-DPR) Patients.
    Biolik G; Gajniak D; Kubicz M; Ziaja D; Ziaja K; Kuczmik W
    Mediators Inflamm; 2019; 2019():3767128. PubMed ID: 31396017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of fibrinogen and von Willebrand factor on clot formation and platelet adhesion in reconstituted and immune thrombocytopenia.
    Misgav M; Shenkman B; Budnik I; Einav Y; Martinowitz U
    Anesth Analg; 2011 May; 112(5):1034-40. PubMed ID: 21474661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
    Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
    J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR; Solymoss S; Flegel KM
    CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
    Prasad RN; Koh SC; Viegas OA; Ratnam SS
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial damage and hemostatic markers in patients with uncomplicated mild-to-moderate hypertension and relationship with risk factors.
    Arikan E; Sen S
    Clin Appl Thromb Hemost; 2005 Apr; 11(2):147-59. PubMed ID: 15821821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.
    Kamiński TW; Pawlak K; Karbowska M; Myśliwiec M; Pawlak D
    BMC Nephrol; 2017 Jan; 18(1):35. PubMed ID: 28122514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).
    Tofler GH; Massaro J; Levy D; Mittleman M; Sutherland P; Lipinska I; Muller JE; D'Agostino RB
    Am J Cardiol; 2005 Nov; 96(9):1280-3. PubMed ID: 16253598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function.
    Li-Saw-Hee FL; Blann AD; Gurney D; Lip GY
    Eur Heart J; 2001 Sep; 22(18):1741-7. PubMed ID: 11511124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up to date concepts about Von Willebrand disease and the diagnose of this hemostatic disorder.
    Buga-Corbu I; Arion C
    J Med Life; 2014 Sep; 7(3):327-34. PubMed ID: 25408749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients].
    Szapáry L; Horváth B; Márton Z; Fehér G; Tóth K; Komoly S
    Orv Hetil; 2008 Jun; 149(24):1117-23. PubMed ID: 18539578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII-mediated global hemostasis in the absence of von Willebrand factor.
    Takeyama M; Kasuda S; Sakurai Y; Shima M; Takeda T; Omura S; Naka H; Yoshioka A
    Int J Hematol; 2007 Jun; 85(5):397-402. PubMed ID: 17562614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of hemostatic alterations in patients affected by Crohn's disease after bowel surgery.
    Chiarantini E; Valanzano R; Liotta AA; Cellai AP; Ilari I; Prisco D; Antonucci E; Tonelli F; Abbate R
    Thromb Res; 1997 Sep; 87(6):539-46. PubMed ID: 9330436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.
    Ikeda Y; Handa M; Kawano K; Kamata T; Murata M; Araki Y; Anbo H; Kawai Y; Watanabe K; Itagaki I
    J Clin Invest; 1991 Apr; 87(4):1234-40. PubMed ID: 2010539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemostasis, platelet function and serotonin in acute and chronic renal failure.
    Malyszko J; Malyszko JS; Pawlak D; Pawlak K; Buczko W; Mysliwiec M
    Thromb Res; 1996 Sep; 83(5):351-61. PubMed ID: 8873344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic response to surgical neutering via ovariectomy and ovariohysterectomy in dogs.
    Moldal ER; Kristensen AT; Peeters ME; Nødtvedt A; Kirpensteijn J
    Am J Vet Res; 2012 Sep; 73(9):1469-76. PubMed ID: 22924730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemostatic coronary risk factors in a healthy population of Maracaibo, Venezuela].
    Diez-Ewald M; Campos G; Rivero F; Alvarez L; Torres E; Arocha-Piñango CL; Ryder E; Arteaga-Vizcaíno M; Vizcaíno G; Fernández N
    Invest Clin; 2003 Mar; 44(1):21-30. PubMed ID: 12703180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of inflammation and hematocrit on clot strength in canine thromboelastographic hypercoagulability.
    Marschner CB; Wiinberg B; Tarnow I; Markussen B; Kühnel L; Bochsen L; Kristensen AT
    J Vet Emerg Crit Care (San Antonio); 2018 Jan; 28(1):20-30. PubMed ID: 29171709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation.
    De Marco L; Girolami A; Zimmerman TS; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7424-8. PubMed ID: 2932740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.